Ana Luisa Gil

I completed my Bachelor’s degree in Biochemistry and my Master’s degree in Molecular Biology and Biotechnology at the University of Murcia. For my Master’s thesis, I worked on the effect of platinum (IV) prodrug-loaded silk fibroin nanoparticles on human ovarian and breast tumor cell lines. This approach showed a significant antitumor effect while maintaining an excellent selectivity index for tumor cells.

In 2015, I joined the Clinical and Experimental Neuroscience group at the University of Murcia and the School for Mental Health and Neuroscience at the Maastricht University to do a double Ph.D. in Neuroscience. During this period, I worked on studying the effect of anti-inflammatory drugs on the progression of dopaminergic neuronal death and glial response in the MPTP-mouse model.

In 2020, I was awarded a Postdoctoral Research Fellowship from Fundación Séneca to join Prof. Mina Ryten’s Lab at the University College London. My postdoctoral project aimed to describe transcriptomic signatures related to the progression of neurodegeneration in Parkinson’s disease.

In 2022, I joined Huw Morris’ group as a Senior Postdoctoral Research Fellow in Neurogenetics to work on the new MRC funded MD-GAP project linking genetics with Parkinson’s disease’s pathology at the UCL Queen Square Institute of Neurology.